Chapter review

Fitzgerald PMHNP board review. ch14. Older Adults. This is drive 6 of 7. When I say Pause. Answer. wait, then I will give the answer. New section. Safety and Complementary Modalities. Topic. Electroconvulsive Therapy (ECT) in Aging. Bottom Line Summary. * **Electroconvulsive therapy (ECT)** is a safe, rapid, and highly effective treatment modality for severe, delusional, or treatment-resistant **major depressive disorder** in older adults over age 65. * Advanced age alone is not a contraindication to **ECT**; age over 65 years is not a reason to avoid treatment when clinically indicated. * Pharmacotherapy in aging requires starting low and going slow, but escalating to effective therapeutic goals to prevent under-treating depression. * Baseline **renal function** and **hepatic function** must be evaluated prior to starting psychotropics due to age-related organ clearance changes in older adults. * High anticholinergic burden from **tricyclic antidepressants (TCAs)** like **amitriptyline** must be avoided in elders due to risks of orthostatic hypotension, cardiac dysrhythmias, urinary retention, and **delirium**. * **Selective serotonin reuptake inhibitors (SSRIs)** like **sertraline** carry a heightened risk of **hyponatremia**, particularly when combined with diuretics like **hydrochlorothiazide** or ACE inhibitors like **lisinopril**. * Polypharmacy is a major geriatric syndrome requiring routine reconciliation of prescription and over-the-counter medications to prevent adverse drug interactions and falls. High-Yield Clinical Teaching. First-line Considerations and Indication Scope. **First-line** pharmacotherapy for mild-to-moderate depression in older adults begins with **SSRIs** due to their favorable safety profile compared to older psychotropics. However, when an older adult presents with severe, life-threatening, catatonic, or treatment-resistant **major depressive disorder**, **ECT** becomes a primary therapeutic intervention. Age over 65 years is not a barrier to receiving **ECT**, and it often produces a faster clinical response with fewer systemic side effects than complex polypharmacy trials in frail elders. Safety Alert: Cardiovascular and Anticholinergic Risks. **Safety alert:** High-risk medications identified in the Beers criteria and STOPP/START guidelines must be avoided in older adults. **Tricyclic antidepressants (TCAs)** like **amitriptyline** cause severe anticholinergic toxicity, presenting as confusion, memory loss, dry mouth, constipation, urinary retention, blurred vision, orthostatic hypotension, and cardiac dysrhythmias. Additionally, **SSRIs** can induce **hyponatremia** via SIADH, presenting with confusion, weakness, postural instability, and acute **delirium**. Board Trap: Misconceptions Regarding ECT in the Elderly. **Board trap:** Exam items often attempt to trick candidates into believing that advanced age makes **ECT** too dangerous or contraindicated. Test writers expect you to recognize that **ECT** is well-tolerated in older adults and is often safer than exposing elderly patients to prolonged, ineffective trials of high-dose psychotropics or severe malnutrition from catatonic depression. Another common trap is assuming mild-to-moderate depression immediately warrants **ECT**; non-psychotic, mild-to-moderate depression is initially managed with low-dose pharmacotherapy and psychotherapy, reserving **ECT** for severe, refractory, or acutely life-threatening presentations. Comprehensive Sample Board Question Inventory. Question 11. When considering therapy for a 71-year-old man with mild to moderate depression, the PMHNP considers all of the following except: A) Medication should be started at low dose and then escalated as needed. B) ECT should be avoided in those over age 65 years. C) Renal and hepatic function should be assessed before initiating pharmacotherapy. D) Medications with less anticholinergic effect should be preferred. Pause. Answer: B Why It Is Correct. Option B is false, making it the correct answer to the exception question. **Electroconvulsive therapy (ECT)** is safe, highly effective, and clinically indicated for severe or treatment-resistant depression in individuals over age 65. Advanced age is not a contraindication to **ECT**. Why the Other Choices Are Wrong. * Option A is incorrect because starting low and going slow, while titrating to therapeutic goals, is standard practice in geriatric psychopharmacology to prevent toxicity while avoiding under-treatment. * Option C is incorrect because evaluating baseline **renal function** and **hepatic function** is an essential prerequisite before starting psychotropic drugs due to age-related changes in clearance and organ function. * Option D is incorrect because selecting agents with minimal anticholinergic activity is vital in older adults to prevent acute cognitive impairment, urinary retention, severe constipation, and orthostatic falls. Next. Topic. Polypharmacy Syndrome. Bottom Line. - **Polypharmacy** is a recognized geriatric syndrome where taking multiple concurrent medications significantly increases drug-drug interactions, adverse effects, and cognitive impairment. - Geriatric prescribing follows the rule to start low and go slow, but clinicians must titrate to therapeutic targets to prevent under-treatment of conditions like major depression. - **SSRIs** like **sertraline** carry a high risk of hyponatremia, which is exacerbated when combined with diuretics such as **hydrochlorothiazide** or ACE inhibitors like **lisinopril**. - **Tricyclic antidepressants** like **amitriptyline** must be avoided in older adults due to severe anticholinergic effects, orthostatic hypotension, and cardiac dysrhythmias. - Sedative-hypnotics like **zolpidem** and long-acting benzodiazepines like **diazepam** double the risk of motor impairment, falls, hip fractures, and acute confusion. - All antipsychotics carry an FDA boxed warning in older adults with major neurocognitive disorders due to a 1.6 to 1.7 times increased risk of mortality, primarily from cardiovascular events or pneumonia. - Baseline **renal function** and **hepatic function** must be evaluated prior to initiating psychotropic pharmacotherapy due to age-related clearance reductions. - **Electroconvulsive therapy** (**ECT**) is safe and highly effective in adults over age 65 with severe or treatment-resistant depression. High-Yield Clinical Concepts. Polypharmacy and Pharmacokinetic Aging Changes. - **What it is:** **Polypharmacy** is a major geriatric syndrome driven by multiple chronic prescriptions, over-the-counter supplements, and age-related changes in drug distribution and clearance. - **First-line:** Conduct a thorough medication reconciliation at every clinical visit, including over-the-counter agents, and check baseline renal and liver function labs before initiating psychotropics. - **Safety alert:** Age-related decreases in renal glomerular filtration rate and hepatic enzyme activity slow drug clearance, causing drug accumulation and toxicity at standard adult doses. - **Board trap:** Clinicians often misinterpret medication side effects as new medical conditions, leading to prescribing cascades where additional drugs are added instead of discontinuing the offending agent. High-Risk Psychotropics and Beers Criteria. - **Tricyclic Antidepressants:** Drugs like **amitriptyline** are contraindicated in older adults due to intense anticholinergic side effects, severe postural hypotension, and dysrhythmias. - **Anticholinergic Toxicity:** Central signs include agitation, anxiety, confusion, hallucinations, delirium, psychosis, seizures, and coma, accompanied by dry mouth, constipation, and urinary retention. - **Sedative-Hypnotics and Benzodiazepines:** Agents such as **zolpidem**, **diazepam**, and **diphenhydramine** increase the risk of falls, hip fractures, motor impairment, and acute delirium. - **Safety alert:** All first-generation and second-generation antipsychotics carry an FDA boxed warning in older adults with major neurocognitive disorders due to a 1.6 to 1.7 fold increase in mortality from heart failure, sudden death, or pneumonia. Hyponatremia and SSRI Therapy. - **What it is:** **SSRIs** such as **sertraline** frequently cause syndrome of inappropriate antidiuretic hormone secretion and hyponatremia in older adults. - **First-line:** Measure baseline serum sodium levels and monitor periodically when starting an **SSRI**, especially in patients taking **hydrochlorothiazide** or **lisinopril**. - **Board trap:** Hyponatremia presents insidiously as subtle lethargy, gait instability, confusion, or falls, which test-takers may incorrectly attribute solely to aging or dementia progression. Depression Management and Interventions. - **First-line:** Select **SSRIs** with minimal anticholinergic activity and favorable drug-interaction profiles, initiating therapy at low doses while actively titrating to therapeutic goals. - **Safety alert:** Do not avoid **ECT** in elderly patients purely because of advanced age. **ECT** is proven safe, rapid, and highly effective for severe, melancholic, or psychotic depression in adults over age 65. Fitzgerald Board-Style Sample Questions. Question 1. According to the Beers criteria and START/STOPP screening tools, matching medications with their primary rationale for caution in older adults reveals which correct association? A. **zolpidem** is associated with significant risk of orthostatic hypotension B. **amitriptyline** is associated with an increased risk of falls and fractures C. **sertraline** is associated with an increased risk of hyponatremia, especially when used with diuretics D. **amitriptyline** is preferred due to its lack of anticholinergic side effects Pause. Answer. **Best Answer:** C **Why It Is Correct:** **sertraline** and other **SSRIs** carry a well-documented risk of hyponatremia in older adults, particularly when co-administered with diuretics like **hydrochlorothiazide**. **Why the Other Choices Are Wrong:** - A: **zolpidem** primarily increases fall and fracture risk through sedation and motor impairment, not orthostatic hypotension. - B: **amitriptyline** causes severe orthostatic hypotension and anticholinergic effects, though falls occur secondarily to hypotension rather than pure sedation. - D: **amitriptyline** has intense anticholinergic effects and should be avoided in older adults. Question 2. A 74-year-old male is brought to the clinic for evaluation of recent erratic behavior, including acute confusion lasting a few hours at a time up to three times daily over the past month. His caregiver reports he recently started a new medication. Which medication is least likely to cause these episodes? A. **diphenhydramine** B. **sertraline** C. **haloperidol** D. **diazepam** Pause. Answer. **Best Answer:** B **Why It Is Correct:** **sertraline** is an **SSRI** and is least likely among the choices to trigger fluctuating delirium or acute confusion in an older adult. **Why the Other Choices Are Wrong:** - A: **diphenhydramine** is a first-generation antihistamine with potent anticholinergic effects that frequently trigger delirium. - C: **haloperidol** is a high-potency antipsychotic that can induce extrapyramidal symptoms, cognitive impairment, or paradoxically worsen delirium. - D: **diazepam** is a long-acting benzodiazepine that causes sedation, ataxia, cognitive clouding, and delirium in elderly patients. Question 3. When evaluating pharmacological treatment for a 71-year-old man with mild to moderate depression, the PMHNP considers all of the following principles except: A. Medication should be started at a low dose and escalated as needed B. **Electroconvulsive therapy** (**ECT**) should be avoided in patients over 65 years of age C. Renal and hepatic function should be assessed before initiating pharmacotherapy D. Medications with lower anticholinergic burden should be preferred Pause. Answer. **Best Answer:** B **Why It Is Correct:** Statement B is false, making it the correct answer to the "except" question. **ECT** is safe, highly effective, and well-tolerated in adults over age 65 with severe or treatment-resistant depression. **Why the Other Choices Are Wrong:** - A: Starting low and titrating gradually is a standard geriatric prescribing rule. - C: Baseline laboratory screening of renal and hepatic clearance is essential prior to prescribing psychotropics. - D: Minimizing anticholinergic side effects prevents confusion, memory impairment, constipation, and urinary retention. Next. New section. Sample Practice Questions: Section 2. Topic. Fitzgerald Q11: Depression Therapy Selection. Bottom Line. - **Electroconvulsive therapy** is safe, well tolerated, and highly effective for patients **over 65 years of age** who suffer from severe or treatment resistant **major depressive disorder**. - Pharmacotherapy in older adults must follow the guideline to **start low and go slow**, but clinicians must actively titrate to therapeutic targets to avoid under treatment. - Baseline **renal function** and **hepatic function** panel testing must be completed prior to initiating psychotropic medications due to age related reductions in clearance. - **Tricyclic antidepressants** such as **amitriptyline** should be avoided in older adults due to severe risks of **orthostatic hypotension**, confusion, and falls. - **Selective serotonin reuptake inhibitors** like **sertraline** are first line for late life **depression**, but patients require monitoring for **hyponatremia**, especially when co prescribed with thiazide diuretics. - Anticholinergic toxicity in geriatric patients presents with dry mouth, constipation, blurry vision, urinary retention, **delirium**, **hallucinations**, **seizures**, and **coma**. Key Signposts. - **First-line**: **SSRIs** such as **sertraline** are the preferred initial pharmacotherapy for **depression** in older adults due to minimal cardiotoxicity and favorable tolerability. - **Safety alert**: High anticholinergic burden from agents like **amitriptyline** or **diphenhydramine** increases the risk of **delirium**, urinary retention, severe constipation, **orthostatic hypotension**, and traumatic falls. - **Board trap**: Selecting an answer that claims **ECT** is unsafe or contraindicated purely based on advanced age. Board questions frequently test the misconception that elderly patients cannot receive **ECT**, when in fact age **over 65 years** is a primary setting where **ECT** demonstrates exceptional efficacy and safety. Sample Practice Question. Question 11. When considering therapy for a 71 year old man with mild to moderate **depression**, the PMHNP considers all of the following EXCEPT: A) Medication should be started at low dose and then escalated as needed. B) **ECT** should be avoided in those over age 65 years. C) **Renal** and **hepatic function** should be assessed before initiating pharmacotherapy. D) Medications with less anticholinergic effect should be preferred. Pause. **Answer:** B **Why It Is Correct:** Statement B is false, which makes it the correct selection for an EXCEPT question. **Electroconvulsive therapy** is both safe and effective in individuals **over 65 years of age**, particularly when treating severe, melancholic, or treatment resistant **depression**. Age itself is not a contraindication to **ECT**. **Why the Other Choices Are Wrong:** - Option A is incorrect because initiating psychotropics at a reduced starting dose and escalating as clinically indicated is a standard, correct principle of geriatric prescribing. - Option C is incorrect because assessing baseline **renal function** and **hepatic function** is an essential, correct safety measure to prevent drug accumulation in older adults. - Option D is incorrect because choosing medications with low anticholinergic profiles is a recommended, correct clinical practice to prevent cognitive decline and central nervous system toxicity. **Test-Taking Pearl:** On certification exams, watch for absolute statements that exclude effective treatments based solely on patient age. **ECT** remains a gold standard option for elderly patients who require rapid response or cannot tolerate oral psychotropics. Clinical Teaching and Spoken Synthesis. When selecting depression therapy for an older adult, advanced practice psychiatric nurses must balance efficacy with physiological vulnerabilities. Normal biological aging leads to decreased glomerular filtration, reduced hepatic blood flow, and altered volume of distribution. These pharmacokinetic changes prolong drug half lives and elevate serum concentrations, increasing the risk of adverse drug reactions. Prescribing in this population follows the mandatory rule to **start low and go slow**. Clinicians typically initiate antidepressant doses at one half or one third of the standard adult starting dose. However, going slow does not mean stopping early. Under treating depression in older adults is a widespread clinical error that leaves patients with persistent functional impairment and higher risk of cognitive decline. Doses must be systematically titrated until full therapeutic response is achieved or side effects limit further escalation. Before starting any psychotropic medication in an older adult, obtaining baseline laboratory data is essential. Evaluation must include **blood urea nitrogen**, **serum creatinine**, **estimated glomerular filtration rate**, and **liver function tests**. Identifying baseline organ impairment allows the provider to select agents with appropriate clearance pathways and adjust initial dosing parameters safely. Medication selection must be guided by safety tools like the **Beers Criteria** and **STOPP START** guidelines. **Tricyclic antidepressants** such as **amitriptyline** carry significant risks for geriatric patients. Their potent blockade of muscarinic acetylcholine receptors causes anticholinergic adverse effects, including dry mouth, urinary retention, worsening constipation, blurred vision, and memory disruption. At higher levels, anticholinergic toxicity can trigger acute **delirium**, agitation, visual **hallucinations**, **seizures**, and cardiac dysrhythmias. Furthermore, alpha 1 adrenergic blockade from **TCAs** causes **orthostatic hypotension**, directly precipitating falls and fractures. For these reasons, **SSRIs** like **sertraline** or **escitalopram** represent the preferred first line pharmacotherapy for geriatric **depression**. Nevertheless, **SSRIs** carry specific risks in older adults, most notably **hyponatremia** secondary to the syndrome of inappropriate antidiuretic hormone secretion. This risk is heightened when an **SSRI** is combined with cardiovascular medications like **hydrochlorothiazide** or **lisinopril**. Serum sodium levels should be checked if an older adult on an **SSRI** develops new onset lethargy, confusion, or gait instability. Finally, **electroconvulsive therapy** is a critical tool in geriatric psychiatry. It is highly effective for older adults, particularly those with severe **depression**, psychotic depression, severe weight loss, or acute suicidality. Misperceptions that advanced age precludes **ECT** are incorrect. When conservative pharmacotherapy fails or rapid clinical response is required for physical survival, **ECT** provides a rapid and safe therapeutic option across the lifespan. Next. New section. Suicide Risk in Older Adults. Topic. Suicide Risk Assessment Factors. Bottom Line. - **Highest risk demographic**: White males aged 65 years and older maintain the highest rate of completed suicide among all geriatric demographic groups. - **Communication of suicidal intent**: Most elderly individuals who commit suicide do communicate their intent prior to the act, frequently using indirect statements, discussing death, or giving away personal possessions. - **Non-independent age factor**: Advancing age itself is not an independent risk factor for **major depressive disorder**, though age-associated psychosocial losses, **living alone**, **alcohol abuse**, and spousal bereavement significantly increase suicide risk. - **Essential inquiry topics**: Diagnostic evaluations for suicide risk in older adults must specifically inquire about **loneliness**, **worthlessness**, and perceived burdensomeness to family or caregivers. - **High comorbidity rate**: Up to 50% of patients diagnosed with a **major neurocognitive disorder** also suffer from co-occurring **major depressive disorder**, compounding suicide risk and functional decline. - **Validated screening tools**: Standardized instruments like the **PHQ-9** are valid, reliable, and recommended for screening depression and suicidal ideation in individuals over 65 years of age across community and long-term care settings. - **Immediate safety priority**: Assessment of active suicide risk, presence of a concrete plan, and access to lethal means must always take precedence over routine diagnostic or pharmacological interventions. Suicide Risk Assessment Factors in Older Adults. High-Yield Risk Factors and Demographics. - **Demographic risk**: Elderly white males aged 65 and older represent the highest statistical risk for completed suicide. - **Precipitating triggers**: Major life disruptions, including the recent death of a spouse, new onset of living alone, severe chronic illness or pain, and **alcohol abuse**, serve as primary triggers. - **Subjective feelings**: High risk correlates strongly with persistent **loneliness**, feelings of **worthlessness**, and perceiving oneself as a burden to loved ones. - **Board trap**: Assuming that suicidal ideation or depressive symptoms are a normal consequence of aging is a critical diagnostic error; late-life depression is pathological and requires immediate intervention. Assessment and Clinical Screening Protocols. - **First-line** action: Administer a validated screening tool, such as the **PHQ-9**, to measure depressive severity and identify suicidal ideation. - Direct inquiry: Explicitly ask about passive thoughts of death, active suicidal intent, specific plans, timelines, and access to lethal means. - Behavioral indicators: Recognize warning signs such as sudden distribution of personal possessions, abrupt revisions to legal wills, or an unexpected period of calm following severe depression. - **Safety alert**: Directly assess for immediate access to firearms, stockpiled prescription medications, or other lethal household items. Differential Diagnostics and Comorbidities. - The three Ds of geriatric psychiatry: Always differentiate and evaluate for **depression**, **dementia** (**major neurocognitive disorder**), and **delirium**. - Comorbidity: Recognize that up to 50% of patients with **major neurocognitive disorder** present with co-occurring **depression**. - Medical mimics: Rule out underlying physiological causes of depressive symptoms, including hypothyroidism, vitamin B12 deficiency, or medication adverse effects, prior to confirming a primary psychiatric diagnosis. Sample Practice Questions. Question 1. Question: During an outpatient evaluation, a PMHNP assesses a 76-year-old male whose wife died four months ago. He lives alone, reports ongoing severe insomnia, and states that he feels like a burden to his family. Which factor represents the highest risk for completed suicide in this patient? - A. Age greater than 65 years - B. Comorbid sleep disturbance - C. Demographic status as an elderly white male living alone - D. Uncomplicated spousal bereavement **Quick Answer**: Option C is correct because elderly white males living alone after spousal loss hold the highest statistical risk for completed suicide. **Key Clue**: Elderly white male living alone after recent death of a spouse. **Best Answer**: C. Demographic status as an elderly white male living alone **Why It Is Correct**: Elderly white males have the highest rate of completed suicide among older adults. Social isolation, recent loss of a spouse, and feeling like a burden drastically elevate this risk. **Why the Other Choices Are Wrong**: - A. Advancing age alone is not an independent risk factor for suicide or **major depressive disorder**. - B. Insomnia is a vegetative symptom of depression but is less predictive of completed suicide than demographic and social isolation variables. - D. Expressing feelings of being a burden alongside severe risk factors indicates pathological **depression** rather than uncomplicated grief. **Test-Taking Pearl**: Prioritize demographic risk, severe social isolation, and access to lethal means when estimating suicide risk on national board exams. Question 2. Question: True or False: Most elderly persons who commit suicide do not talk about their plans or display warning signs prior to the act. - A. True - B. False **Quick Answer**: Option B is correct because most elderly individuals who commit suicide communicate their intent directly or indirectly before attempting. **Key Clue**: Talking about plans or displaying warning signs. **Best Answer**: B. False **Why It Is Correct**: Older adults frequently communicate suicidal intent through direct statements, indirect comments about death, or behavioral changes such as giving away personal possessions or making sudden final arrangements. **Why the Other Choices Are Wrong**: - A. Believing that older adults do not communicate suicidal intent is a dangerous clinical myth and a common **board trap**. **Test-Taking Pearl**: Never dismiss subtle verbal or behavioral cues in older adults; indirect statements regarding death or being a burden require immediate safety evaluation. Question 3. Question: True or False: Standardized screening instruments for depression, such as the **PHQ-9**, are invalid for patients over 65 years of age. - A. True - B. False **Quick Answer**: Option B is correct because standardized screening instruments remain valid and effective for older adults. **Key Clue**: Validity of depression screening instruments in adults over 65. **Best Answer**: B. False **Why It Is Correct**: Standardized depression screening instruments, including the **PHQ-9**, are validated, reliable, and routinely utilized for individuals over age 65 across outpatient, acute, and nursing home settings. **Why the Other Choices Are Wrong**: - A. Claiming that screening tools are invalid in older adults is incorrect and contradicts national standards of care. **Test-Taking Pearl**: Utilize validated screening tools like the **PHQ-9** to screen older adults for depression across all clinical practice environments. Active Recall Questions. 1. Which specific demographic group among older adults has the highest rate of completed suicide? 2. Is advancing age independently classified as a direct risk factor for **major depressive disorder**? 3. What percentage of patients with a **major neurocognitive disorder** also experience co-occurring **depression**? 4. What three specific subjective feelings must clinicians directly inquire about during a geriatric suicide risk assessment? 5. How do older adults commonly express suicidal intent prior to a suicide attempt? Next Study Step. - **Recommended topic**: Neurocognitive Disorders and Delirium Assessment in Fitzgerald Chapter 14. - **Why this is next**: Mastering the clinical differentiation between **major neurocognitive disorder**, **delirium**, and late-life **depression** ensures rapid identification of medical emergencies and accurate diagnostic formulation. 💡 *Next step*: We can explore the diagnostic criteria and differential features between **delirium** and **major neurocognitive disorder**, or dive into the high-yield **Beers Criteria** medication safety rules for older adults. Which area would you like to cover next? Next. Topic. Screening Tools for Older Adults. Bottom Line Summary. - **Geriatric Depression Scale (GDS)**: A 30-item self-report questionnaire or 15-item short version specifically validated for detecting depression and tracking treatment response in older adults [1, 2]. - **PHQ-9 Validation in Late Life**: Validated for use in adults 65 years and older, including nursing home residents, with scores of 10 or higher indicating moderate depression [1, 2]. - **Suicide Communication Myth**: Most elderly individuals who commit suicide communicate their intent prior to the act through direct statements, indirect comments, or giving away personal belongings [3, 4]. - **Demographic Vulnerability**: Elderly white males age 65 and older represent the population with the highest completed suicide rate among older adults [3, 4]. - **Age as an Independent Risk Factor**: Advancing age itself is not an independent risk factor for major depression, although physical losses and medical comorbidities increase overall vulnerability [2, 3]. - **Co-occurring Depression in Dementia**: Up to 50% of patients with major neurocognitive disorders suffer from co-occurring major depressive disorder source 4. - **Mini-Cog Assessment**: Combines a 3-item word recall with a clock drawing test to screen rapidly for cognitive impairment and executive dysfunction [5, 6]. High-Yield Signposts and Exam Rules. - **Safety alert**: Older adults expressing passive death wishes, feelings of burdensomeness, or giving away personal items require immediate suicide risk assessment, environmental safety planning, and lethal means restriction [3, 4]. - **Board trap**: Believing that depression is a normal physiological part of aging or that suicidal elderly patients do not talk about their plans [2-4]. On the exam, both assumptions are false [2, 3]. - **First-line**: Selective serotonin reuptake inhibitors (SSRIs) such as **sertraline** or **escitalopram** are first-line pharmacotherapy for late-life major depression, initiated at half the typical starting dose [7-9]. Compare and Distinguish Screening Tools. Geriatric Depression Scale vs. PHQ-9. - **Geriatric Depression Scale (GDS)**: Specifically designed for older adults by minimizing somatic items (such as fatigue or constipation) that can overlap with physical medical conditions [1, 2]. - **PHQ-9**: Standardized 9-item tool assessing both somatic and cognitive symptoms of depression, validated across adult age groups including long-term care settings [1, 2]. Geriatric Depression Scale vs. Cornell Scale for Depression in Dementia. - **Geriatric Depression Scale (GDS)**: Relies on patient self-report using a simple yes or no format, requiring mild to intact cognitive function [1, 2]. - **Cornell Scale for Depression in Dementia**: Utilizes clinician observation and informant interviews to evaluate depressive symptoms in patients with moderate to severe dementia who cannot self-report accurately [4, 10]. Mini-Cog vs. Montreal Cognitive Assessment (MoCA). - **Mini-Cog**: A rapid 3-minute screening tool consisting of a 3-item word recall and a clock drawing test to detect general cognitive impairment [5, 6]. - **MoCA**: A comprehensive 30-point screening tool evaluating six cognitive domains (memory, executive function, language, visuospatial, attention, orientation) to detect mild cognitive impairment [10, 11]. Board-Style Practice Questions. Question 1. Question: True or False: Most standardized screening instruments for depression are not valid in people over 65 years of age. - A. True - B. False Pause. Answer: B source 1. Why it is correct: Standardized depression screening instruments such as the **PHQ-9** and **Geriatric Depression Scale (GDS)** are fully validated and routinely utilized in adults over 65 years of age across community and long-term care settings [1, 2]. Why the other choices are wrong: - A: True is incorrect because age alone does not invalidate standardized depression screening tools [1, 2]. Question 2. Question: True or False: Advanced age is an independent risk factor for developing depression. - A. True - B. False Pause. Answer: B source 2. Why it is correct: Advancing age itself is not an independent risk factor for major depression [2, 3]. Late-life depression stems from psychosocial losses, functional decline, and medical comorbidities rather than aging itself [2, 3]. Why the other choices are wrong: - A: True is incorrect because major depression is a pathological condition and not a normal consequence of growing older [2, 3]. Question 3. Question: True or False: Most elderly persons who commit suicide do not talk about their plans. - A. True - B. False Pause. Answer: B source 3. Why it is correct: Older adults frequently communicate suicidal intent through direct statements, indirect comments, or behavioral changes such as giving away personal possessions [3, 4]. Why the other choices are wrong: - A: True is incorrect because assuming elderly patients do not talk about suicide plans is a dangerous misconception that leads to missed clinical intervention [3, 4]. Question 4. Question: True or False: Up to 50 percent of individuals with major neurocognitive disorders also suffer from depression. - A. True - B. False Pause. Answer: A source 4. Why it is correct: Major depression co-occurs in up to 50% of individuals with major neurocognitive disorders, highlighting the significant overlap among the "three Ds" of geriatric psychiatry: **depression**, **dementia**, and **delirium** [4, 7]. Why the other choices are wrong: - B: False is incorrect because depressive symptoms are highly prevalent in patients experiencing neurocognitive decline source 4. Next. New section. Elder Abuse and Caregiver Support. Topic. Elder Abuse Realities. Bottom Line Summary. 1. **Elder abuse prevalence**: Most elder abuse occurs in domestic settings and is perpetrated by family members or primary caregivers, often going unreported due to fear of retaliation, guilt, or lack of alternative support. 2. **Abuse classification**: Types of elder abuse include physical abuse, emotional or psychological abuse, sexual abuse, financial exploitation, caregiver neglect, and self-neglect. 3. **Mandatory reporting**: Advanced practice nurses are mandatory reporters required to notify **Adult Protective Services** immediately upon reasonable suspicion of elder abuse, neglect, or financial exploitation. 4. **Caregiver burden**: Neuropsychiatric symptoms occur in 98% of patients with **major neurocognitive disorder** and directly drive caregiver burnout, high healthcare costs, and early nursing home placement. 5. **First-line interventions**: Non-pharmacological strategies such as adult day centers, respite care, support groups, and home safety modifications are **first-line** choices to relieve caregiver strain and enable aging in place. 6. **Antipsychotic boxed warning**: A **safety alert** applies to all **antipsychotics** due to a 1.6 to 1.7 times increased risk of mortality in older adults with dementia-related psychosis, primarily from cardiovascular events or pneumonia. 7. **Advance care planning**: Discussions regarding decision-making capacity, living wills, and durable power of attorney should occur early while the patient retains cognitive ability. High-Yield Concepts: Elder Abuse and Caregiver Support. Elder Abuse Types, Signs, and Perpetrators. - **Perpetrator demographics**: Family members and co-residing primary caregivers account for the majority of elder abuse cases, frequently driven by caregiver stress, substance use, or financial dependency. - **Physical indicators**: Unexplained fractures, bruises in various stages of healing, lacerations, burns, or traumatic hair loss require immediate clinical investigation. - **Neglect indicators**: Malnutrition, dehydration, unmanaged pressure ulcers, dirty clothing, unfulfilled prescriptions, or hazardous living conditions signify caregiver neglect. - **Financial exploitation**: Unexplained withdrawals from bank accounts, sudden changes to wills or legal documents, or missing personal property indicate financial abuse. - **Reporting mandate**: Reasonable suspicion obligates the provider to report to **Adult Protective Services**. Proof is not required, and patient consent is not needed to file a report. Caregiver Burden and Support Strategies. - **Prevalence of behavioral symptoms**: Neuropsychiatric symptoms affect 98% of patients with **major neurocognitive disorder**, causing severe caregiver exhaustion and distress. - **Respite and day programs**: Adult day centers provide structured social activities for the patient while giving caregivers essential respite to prevent burnout. - **Home safety modifications**: Essential interventions include stove shut-off devices, door alarms for wandering prevention, fall risk reduction, and financial protection from scams. - **Advance directives**: Establishing advance care planning early ensures patient preferences regarding aggressive medical interventions are documented before severe cognitive decline occurs. Compare and Distinguish. Caregiver Neglect vs. Self-Neglect. - **Think Caregiver Neglect:** Failure of an assigned caregiver to fulfill obligations for food, shelter, clothing, medical care, or hygiene. - **Think Self-Neglect:** Failure of an isolated older adult with cognitive or physical impairment to perform basic self-care tasks. - **Priority:** Caregiver neglect requires mandatory reporting to **Adult Protective Services**. Self-neglect requires functional capacity assessment and community support services. Delirium-Induced Agitation vs. Behavioral Symptoms of Dementia. - **Think Delirium-Induced Agitation:** Abrupt onset over hours to days, fluctuating course, impaired attention, and an acute underlying physical cause like urinary tract infection or hyponatremia. - **Think Behavioral Symptoms of Dementia:** Gradual onset over months, stable level of consciousness, triggered by routine disruption or environmental overload. - **Priority:** **Delirium** requires urgent medical evaluation and correction of the physical trigger. Dementia-related behavioral symptoms require non-pharmacological redirection and caregiver support. Critical Exam Signposts. Safety Alert. PMHNPs are mandatory reporters of suspected elder abuse, neglect, and financial exploitation. Reasonable suspicion requires an immediate report to **Adult Protective Services** without waiting for definitive proof or patient permission. Board Trap. Selecting a **second-generation antipsychotic** to manage mild verbal outbursts, wandering, or caregiver stress in an older adult with **Alzheimer's disease**. **Antipsychotics** carry a boxed warning for increased mortality in older adults with dementia. Use non-pharmacological approaches and caregiver respite **first-line**. First-Line. **First-line** intervention for caregiver burnout is connecting the family to community resources, adult day centers, respite care, and the **Alzheimer's Association**. Board Practice Questions. Question 1. A 78-year-old woman with recently diagnosed **Alzheimer's disease** is brought to the outpatient clinic by her 55-year-old daughter for a routine follow-up. The daughter reports feeling overwhelmed because her mother struggles with word finding, occasionally exhibits apathy, and recently had an angry verbal outburst when her morning routine was delayed. The daughter states that this behavior is entirely out of character for her mother, but she wants her mother to remain living at home safely for as long as possible. What is the most appropriate initial action by the PMHNP? - A. Prescribe a low dose of **quetiapine** to control the patient's angry verbal outbursts. - B. Recommend immediate placement in a long-term memory care facility to prevent caregiver burnout. - C. Perform a home safety evaluation, assess for concomitant mood or medical causes, and refer the daughter to caregiver support resources. - D. Discontinue **cholinesterase inhibitor** therapy because it has failed to maintain the patient's cognitive baseline. Pause. Answer: C Why C is correct: The PMHNP must prioritize comprehensive safety, rule out co-occurring mood or medical issues, and provide non-pharmacological caregiver support. Home safety modifications, evaluating for underlying depression or medical triggers, and connecting the caregiver to adult day care or support groups address both patient safety and caregiver strain without unnecessary medication risks. Why the other choices are wrong: - Option A is incorrect because **antipsychotics** carry a boxed warning for increased mortality in older adults with neurocognitive disorders and are reserved solely for severe agitation presenting immediate physical danger. - Option B is incorrect because premature institutionalization contradicts the family's goal to age in place when community and home support resources have not yet been utilized. - Option D is incorrect because **cholinesterase inhibitors** provide modest symptomatic benefit and should not be abruptly discontinued simply because disease progression or behavioral fluctuations occur. Question 2. During a home visit with an 82-year-old male with **major neurocognitive disorder**, the PMHNP observes multiple unexplained stage 2 pressure ulcers, severe weight loss, unwashed clothing, and a lack of required cardiac medications in the home. The patient's adult son, who lives with him and manages his social security funds, appears hostile and refuses to answer questions about the patient's care. What is the most appropriate initial action by the PMHNP? - A. Instruct the son on proper wound care and schedule a follow-up visit in two weeks. - B. File an immediate report with **Adult Protective Services** based on suspected elder neglect and financial exploitation. - C. Obtain a court order to revoke the son's power of attorney before taking further action. - D. Confront the son directly about the missing medications and demand bank statements. Pause. Answer: B Why B is correct: PMHNPs are mandatory reporters of suspected elder abuse, neglect, and financial exploitation. The presence of unexplained physical neglect, unmanaged medical needs, and suspicious caregiver behavior creates reasonable suspicion, which triggers the legal obligation to report to **Adult Protective Services** immediately. Why the other choices are wrong: - Option A is incorrect because providing education without reporting leaves a vulnerable adult in an unsafe environment with unaddressed severe neglect. - Option C is incorrect because legal proceedings regarding power of attorney are outside the NP's direct mandate and delay urgent protection for the patient. - Option D is incorrect because confronting a hostile suspected abuser may escalate harm to the patient and interfere with official protective investigations. 💡 Would you like to create a set of practice flashcards or a targeted quiz on Chapter 14 geriatric psychopharmacology and Beers Criteria risks next? Next. End of this drive.